TARGETED INTEGRATION OF NUCLEIC ACIDS

    公开(公告)号:US20210403953A1

    公开(公告)日:2021-12-30

    申请号:US17351451

    申请日:2021-06-18

    Abstract: The presently disclosed subject matter relates to targeted integration (TI) host cells suitable for the expression of recombinant proteins wherein those TI host cells have been subjected to supertransfection resulting in the random integration (RI) of exogenous nucleic acids encodes into their genome, as well as methods of producing and using said supertransfected TI host cells.

    MODIFIED MAMMALIAN CELLS
    2.
    发明申请

    公开(公告)号:US20210309989A1

    公开(公告)日:2021-10-07

    申请号:US17213611

    申请日:2021-03-26

    Abstract: The present disclosure relates to methods, cells, and compositions for producing a product of interest, e.g., a recombinant protein. In particular, the present disclosure provides improved mammalian cells expressing the product of interest, where the cells (e.g., Chinese Hamster Ovary (CHO) cells) have reduced or eliminated activity, e.g., expression, of certain host cell proteins, e.g., enzymes including, but not limited to, certain lipases, esterases, and/or hydrolases.

    MODIFIED MAMMALIAN CELLS
    6.
    发明申请

    公开(公告)号:US20250101411A1

    公开(公告)日:2025-03-27

    申请号:US18823189

    申请日:2024-09-03

    Abstract: The present disclosure relates to methods, cells, and compositions for producing a product of interest, e.g., a recombinant protein. In particular, the present disclosure provides improved mammalian cells expressing the product of interest, where the cells (e.g., Chinese Hamster Ovary (CHO) cells) have reduced or eliminated activity, e.g., expression, of certain host cell proteins, e.g., enzymes including, but not limited to, certain lipases, esterases, and/or hydrolases.

Patent Agency Ranking